Cited by 101T-cell and B-cell ImmunologyProbiotics and Fermented FoodsImmunotherapy and Immune Responses

Treg-inducing membrane vesicles from Bifidobacterium bifidum LMG13195 as potential adjuvants in immunotherapy

Open access
López, Patricia, González-Rodríguez, Irene, Sánchez, Borja, Gueimonde, Miguel, Margolles, Abelardo, Suárez, Ana·2012·Vaccine

Abstract

Allergen-specific immunotherapy is the only treatment shown to induce antigen-specific regulatory T (Treg) cells and peripheral tolerance to restore human homeostasis. Specific probiotic strains are valid candidates to improve the allergen-specific tolerance, since they are able to generate Treg cells from naïve precursors. We recently reported that exposing dendritic cells (DCs) to Bifidobacterium bifidum LMG13195 in vitro induced the polarization of naïve T cells into functional Treg cells. In the present study, we evaluated the ability of DCs exposed to different B. bifidum subcellular fractions to promote Treg differentiation. We found that DCs exposed to B. bifidum LMG13195 membrane vesicles most strongly promoted differentiation of functional CD25(high)FOXP3(high)CD127(-/low) Treg cells as well as induced the highest IL-10 levels respect to the proinflammatory cytokines IFNγ, TNFα and IL-17. Our results suggest the potential use of B. bifidum LMG13195 membrane vesicles as a safe and clinically effective adjuvant for immunotherapy.

Integrity signals

Registry

Crossref · 10.1016/j.vaccine.2011.11.115

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Each Bifidobacterium species appeared to elicit different immune effects on the host, noteworthy being the ability of B. bifidum to expand the T-regulatory response, which may be relevant for its use in chronic inflammatory diseases.

    “Each Bifidobacterium species appeared to elicit different immune effects on the host, noteworthy being the ability of B. bifidum to expand the T-regulatory response, which may be relevant for its use in chronic inflammatory diseases (104).”

    From Bifidobacteria and Their Health-Promoting Effects (2017) · cites this paper as [104]

The citation lists haven’t been fetched yet

References 22 · Cited by 101

Authors
López, P., González-Rodríguez, I., Sánchez, B., Gueimonde, M., Margolles, A., & Suárez, A.
Affiliations
  • Consejo Superior de Investigaciones Científicas (ES)
  • Universidad de Oviedo (ES)
Venue
Vaccine
Publisher
Elsevier BV
Published
2012-01
Volume
30
Issue
5
Pages
825-829
ISSN
0264-410X (ISSN-L)
OpenAlex
W2084730809
Cited by
101
References
22
Citations by year
2026: 8 · 2025: 8 · 2024: 13 · 2023: 10 · 2022: 15 · 2021: 10 · 2020: 8 · 2019: 5 · 2018: 8 · 2017: 3 · 2016: 3 · 2015: 1 · 2014: 2 · 2013: 4 · 2012: 3
FWCI
1.27
Type
journal article
Language
en
Open access
Locations
  • Vaccine (publishedVersion)
  • PubMed (publishedVersion)
  • Consultation of the Doctoral Thesis Database (TESEO) (Ministerio de Educación, Cultura y Deporte) (submittedVersion, cc-by-nc-nd)
  • DIGITAL.CSIC (Spanish National Research Council (CSIC)) (submittedVersion)
Funders
  • European Union FEDER funds and the Spanish Plan Nacional de I+D (AGL2007-61805, AGL2010-14952)
  • Spanish Ministerio de Ciencia e Innovación
Topics
  • Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
  • Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
  • Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
Keywords
Bifidobacterium bifidum, membrane vesicles, regulatory T cells, allergen immunotherapy, probiotics, dendritic cells, adjuvants, Foxp3, IL-10, subcellular fractions, peripheral tolerance
MeSH terms
Adjuvants, Immunologic, Allergens, Bifidobacterium, Dendritic Cells, Humans, Hypersensitivity, Immunotherapy, Interferon-gamma, Tumor Necrosis Factor-alpha, Interleukin-10, Interleukin-17, Secretory Vesicles, T-Lymphocytes, Regulatory, Forkhead Transcription Factors, Interleukin-2 Receptor alpha Subunit, Interleukin-7 Receptor alpha Subunit

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review